OMCL (Omnicell) Float Percentage Of Total Shares Outstanding : 69.80% (As of May. 03, 2025)

View and export this data going back to 2001. Start your Free Trial

What is Omnicell Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Omnicell's float shares is 32.69 Mil. Omnicell's total shares outstanding is 46.84 Mil. Omnicell's float percentage of total shares outstanding is 69.80%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Omnicell's Insider Ownership is 3.73%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Omnicell's Institutional Ownership is 97.16%.

Omnicell Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Omnicell's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	32.69	/	46.84
	=	69.80%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omnicell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicell Inc (NAS:OMCL) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

4220 North Freeway, Fort Worth, Santa Clara, CA, USA, 76137

Website

https://www.omnicell.com

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

Executives

Randall A Lipps	director, officer: President and CEO	1101 EAST MEADOW DR, PALO ALTO CA 94303
Mark W Parrish	director	BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Kaushik Ghoshal	director	9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
Christine Marie Mellon	officer: EVP, Chief People Officer	590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Nchacha Etta	officer: EVP & CFO	4220 NORTH FREEWAY, FORT WORTH TX 76137
Joanne B Bauer	director	1400 HOLCOMB BRIDGE ROAD, ROSWELL GA 30076-2199
Scott Peter Seidelmann	officer: EVP, Chief Commercial Officer	590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Peter J. Kuipers	officer: Executive V.P. CFO	590 E. MIDDLEFEILD ROAD, MOUNTAIN VIEW CA 94043
Mary Garrett	director	ETHAN ALLEN DRIVE, DANBURY CT 06811
Manley Corey J	officer: SR. VP & CHIEF LEGAL OFFICER	590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Dan S Johnston	officer: V.P., Legal & General Counsel
Joseph Brian Spears	officer: Chief Accounting Officer & VP	590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
James T Judson	officer: VP Finance & Acting CFO	C/O OMNICELL, INC., 1201 CHARLESTON ROAD, MOUNTAIN VIEW CA 94043
Robin Gene Seim	officer: V.P., Finance & CFO	1201 CHARLESTON ROAD, MOUNTAIN VIEW CA 94043
Edward Peter Bousa	director	280 CONGRESS STREET, BOSTON MA 02210